T1	p 109 167	patients with primary Raynaud 's phenomenon in South Korea
T2	p 740 761	Ninety-three subjects
T3	p 1114 1129	Korean patients
T4	p 1171 1182	RP patients
T5	i 44 72	nifedipine sustained release
T6	i 78 99	Ginkgo biloba extract
T7	i 256 284	nifedipine sustained release
T8	i 287 300	nifedipine SR
T9	i 317 338	Ginkgo biloba extract
T10	i 456 469	nifedipine SR
T11	i 495 516	Ginkgo biloba extract
T12	i 1023 1036	nifedipine SR
T13	i 1061 1082	Ginkgo biloba extract
T14	o 21 29	efficacy
T15	o 34 40	safety
T16	o 233 241	efficacy
T17	o 246 252	safety
T18	o 650 691	percent improvement of the RP attack rate
T19	o 911 933	serious adverse events
T20	o 956 970	adverse events
T21	o 1046 1055	effective
T22	o 1148 1157	tolerable